Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs
- PMID: 6206312
- DOI: 10.1097/00005344-198407000-00007
Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs
Abstract
In animals and man, the selective alpha 1-adrenoceptor antagonist indoramin reduces arterial pressure without increasing heart rate. We studied this mechanism of absence of reflex tachycardia in anaesthetised dogs. Indoramin reduced (p less than 0.05) arterial pressure with no reflex increase in heart rate, whereas phenoxybenzamine reduced (p less than 0.05) pressure but increased (p less than 0.05) heart rate. Atropine and propranolol pretreatment, vagotomy and division of the cardio-accelerator nerve did not prevent the reduction (p less than 0.05) in arterial pressure and heart rate seen with indoramin. Mexiletine, a drug which has membrane-stabilising activity, had no effect on heart rate or arterial pressure. Mexiletine and indoramin did not affect the increases in heart rate produced by stimulation of the cardio-accelerator nerve. Indoramin reduced (p less than 0.05) the increases in heart rate and arterial pressure produced by bilateral carotid occlusion, and potentiated the arterial pressure reduction but attenuated the heart rate response to intravenous isoprenaline. It also reduced (nonsignificantly) the responses to intravenous noradrenaline and phenylethylamine but had no effect on the arterial pressure and heart rate responses to bilateral central vagal stimulation. We conclude that the absence of the reflex tachycardia with hypotensive doses of indoramin does not result from the myocardial membrane-stabilising action of indoramin or from alteration in sympathetic and parasympathetic activity, but may occur partly from a reduction in baroreceptor sensitivity.
Similar articles
-
Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.Drugs. 1986 Jun;31(6):467-99. doi: 10.2165/00003495-198631060-00002. Drugs. 1986. PMID: 3525084 Review.
-
Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.Br J Pharmacol. 1986 Feb;87(2):433-41. doi: 10.1111/j.1476-5381.1986.tb10834.x. Br J Pharmacol. 1986. PMID: 3955309 Free PMC article.
-
Differential blockade of alpha-adrenoceptors by indoramin.Br J Clin Pharmacol. 1984 Jun;17(6):719-28. doi: 10.1111/j.1365-2125.1984.tb02409.x. Br J Clin Pharmacol. 1984. PMID: 6146328 Free PMC article.
-
The effect of prazosin, indoramin and phentolamine on sympathetic nerve activity.Eur J Pharmacol. 1984 Nov 27;106(3):507-13. doi: 10.1016/0014-2999(84)90054-2. Eur J Pharmacol. 1984. PMID: 6097460
-
Investigations into the bradycardic action of indoramin.Arzneimittelforschung. 1985;35(1A):301-5. Arzneimittelforschung. 1985. PMID: 4039170
Cited by
-
Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?Br J Clin Pharmacol. 1985 Feb;19(2):266-71. doi: 10.1111/j.1365-2125.1985.tb02642.x. Br J Clin Pharmacol. 1985. PMID: 3885983 Free PMC article. Clinical Trial.
-
Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.Drugs. 1986 Jun;31(6):467-99. doi: 10.2165/00003495-198631060-00002. Drugs. 1986. PMID: 3525084 Review.
-
Effect of acute and chronic oral administration of alfuzosin on baroreflex function and tremor in man.Br J Clin Pharmacol. 1988 Apr;25(4):417-24. doi: 10.1111/j.1365-2125.1988.tb03324.x. Br J Clin Pharmacol. 1988. PMID: 3382587 Free PMC article. Clinical Trial.
-
Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.Br J Pharmacol. 1986 Feb;87(2):433-41. doi: 10.1111/j.1476-5381.1986.tb10834.x. Br J Pharmacol. 1986. PMID: 3955309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources